Single-cell transcriptomics uncover hub genes and cell–cell crosstalk in patients with hypertensive nephropathy

Rong Tang,Wei Lin,Chanjuan Shen,Xueling Hu,Leilin Yu,Ting Meng,Linlin Zhang,Peter J Eggenhuizen,Joshua D Ooi,Peng Jin,Xiang Ding,Xiangcheng Xiao,Yong Zhong,Peter J. Eggenhuizen,Joshua D. Ooi
DOI: https://doi.org/10.1016/j.intimp.2023.111104
IF: 5.714
2023-11-02
International Immunopharmacology
Abstract:Hypertensive nephropathy (HTN) is one of the leading causes of end-stage renal disease, yet the molecular mechanisms are still unknown. To explore novel mechanisms and gene targets for HTN, the gene expression profiles of renal biopsy samples obtained from 2 healthy living donor controls and 5 HTN patients were determined by single-cell RNA sequencing. Key hub genes expression were validated by the Nephroseq v5 platform. The HTN endothelium upregulated cellular adhesion genes ( ICAM2 and CEACAM1 ), inflammatory genes ( ETS2 and IFI6 ) and apoptosis related genes ( CNN3) . Proximal tubules in HTN highly expressed hub genes including BBOX1 , TPM1 , TMSB10 , SDC4 , and NUP58, which might be potential novel targets for proximal tubular injury. The upregulated genes in tubules of HTN were mainly participating in inflammatory signatures including IFN-γ signature, NF-κB signaling, IL-12 signaling and Wnt signaling pathway. Receptor-ligand interaction analysis indicated potential cell–cell crosstalk between endothelial cells or mesangial cells with other renal resident cells in HTN. Together, our data identify a distinct cell-specific gene expression profile, pathogenic inflammatory signaling and potential cell–cell communications between endothelial cells or mesangial cells with other renal resident cells in HTN. These findings may provide a promising novel landscape for mechanisms and treatment of human HTN.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?